XTLB

XTL Biopharmaceuticals Ltd. XTLB

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode XTLB CYCN XBIO NRSN TTNP IBO PLRZ TCRT AIM ALZN
6M 25.66 % -11.90 % 93.95 % 16.98 % 52.15 % 18.25 % -98.81 % 10.00 % -33.75 % -66.08 %
YTD -27.92 % -27.96 % 18.77 % 7.83 % 77.43 % -60.84 % -99.76 % 61.93 % -87.95 % -78.52 %
1Y -28.64 % -2.47 % 26.91 % 29.57 % 20.43 % -59.52 % -99.71 % 44.34 % -89.81 % -84.56 %
3Y 17.36 % -66.14 % -10.59 % -24.39 % -71.12 % -99.84 % -99.71 % -98.15 % -94.59 % -99.85 %
5Y -29.00 % -96.01 % -47.77 % -69.31 % -93.26 % -99.84 % -99.71 % -99.19 % -98.85 % -99.99 %
10Y -84.65 % -99.05 % -99.21 % -69.31 % -99.97 % -97.59 % -99.71 % -99.81 % -99.97 % -99.99 %
From the beginning -99.75 % -99.05 % -99.21 % -69.31 % -100.00 % -97.59 % -99.71 % -99.87 % -71.10 % -99.99 %

Dividend